Pfizer Inc. (LON:0Q1N)

Market Cap	100.15B
Revenue (ttm)	46.55B
Net Income (ttm)	7.84B
Shares Out	n/a
EPS (ttm)	1.38
PE Ratio	12.77
Forward PE	8.53
Dividend	1.31 (5.45%)
Ex-Dividend Date	Jul 25, 2025

Volume	255,037
Average Volume	63,393
Open	24.85
Previous Close	24.78
Day's Range	23.95 - 24.91
52-Week Range	20.77 - 30.41
Beta	0.46
RSI	39.81
Earnings Date	Oct 28, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1N

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD